بدائل البحث:
lower decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), we decrease (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), gy decreased (توسيع البحث)
lower decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), we decrease (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), gy decreased (توسيع البحث)
-
2141
Bacterial strains used in this study.
منشور في 2025"…The proportion of Smurf individuals was significantly lower in <i><i>C. elegans</i></i> fed <i><i>P. copri</i></i> cultured in TJ medium than in those fed the same bacteria cultured in normal medium, while other strains showed no such medium-dependent differences. …"
-
2142
-
2143
-
2144
Risk of bias across 22 included studie.
منشور في 2024"…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …"
-
2145
An overview of the selection process for studies.
منشور في 2024"…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …"
-
2146
Characteristics of studies (<i>n</i> = 22).
منشور في 2024"…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …"
-
2147
-
2148
-
2149
-
2150
Patients’ responses to EQ5-D items.
منشور في 2024"…Moreover, patients with only an elementary education had significantly lower EQ5-D scores compared to those with a postgraduate education (-0.106, 95%CI (-0.190, -0.023), p = 0.013).…"
-
2151
-
2152
-
2153
-
2154
Study-related adverse events.
منشور في 2025"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"
-
2155
Study flow chart.
منشور في 2025"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"
-
2156
Study CONSORT diagram.
منشور في 2025"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"
-
2157
Data Sheet 1_Trends in lower extremity peripheral arterial disease incidence since 1990 and forecasting future statistics using Global Burden of Disease 2021: a time-series analysi...
منشور في 2025"…Background<p>Lower extremity peripheral arterial disease (LEPAD) significantly affects quality of life and is associated with severe cardiovascular risks. …"
-
2158
Baseline characteristics of the study sample<sup>β</sup>μ.
منشور في 2024"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"
-
2159
The flow diagram of the study (CONSORT, 2010).
منشور في 2024"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"
-
2160